Alimera sciences appoints jason werner as chief operating officer

Atlanta, oct. 03, 2023 (globe newswire) -- alimera sciences, inc. (nasdaq: alim) (“alimera”), a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer, today announced the appointment of jason werner, chief operating officer (“coo”), effective october 2, 2023. in conjunction with this appointment, dr. philip ashman, previously alimera's chief operating officer and senior vice president, commercial operations europe, was appointed president of international operations.
ALIM Ratings Summary
ALIM Quant Ranking